Systemic Inflammatory Response Syndrome Clinical Trial
Official title:
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis - Procalcitonin, Presepsin. Correlation With Blood Culture and Detection of Infection by Molecular Biological Methods
The aim of the study is to measure serum levels of myristic acid in septic patients and to compare them with myristic acid serum levels in patients with Systemic Inflammatory Response Syndrome of non infective etiology and in healthy volunteers. Furthermore, other biomarkers of sepsis are evaluated in comparison with microbiological findings detected either by standard hemocultures or by molecular biological methods.
Currently, there is an array of biomarkers potentially useful in diagnosis and prognosis in septic patients, either alone or in combination. Only a fraction of them is used in clinical practice. The reasons vary, low sensitivity or specificity is the main one, cost/benefit or difficult processing with the need of highly specialized laboratory to name the other. Recent pilot study from Swedish authors (A.M.Kauppi et al.) published in 2016 showed high correlation of myristic acid levels in blood in patients with sepsis and bacteraemia. There was no other publication on this molecule in relation to sepsis before. Cambiaghi et al. observed its significant decrease in nonresponders to the treatment of septic shock. Myristic acid is an organic acid of linear structure. Measurement of its level will be performed using gas chromatography linked with mass spectrometry. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02518087 -
Increased Adsorption Membranes During Cardiopulmonary Bypass
|
N/A | |
| Completed |
NCT02902939 -
Myeloid-Derived Supressor Cells in Cardiac Surgery Patients
|
N/A | |
| Completed |
NCT02563652 -
Can Biomarkers Aid in the Prediction of Postoperative Pain and Circulatory Instability After Major Abdominal Surgery?
|
||
| Recruiting |
NCT01157299 -
Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO
|
N/A | |
| Completed |
NCT01388725 -
Comparison the Value of Several Biomarkers of Sepsis
|
N/A | |
| Unknown status |
NCT00254176 -
Cysteine Supplementation in Critically Ill Neonates
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT03617796 -
Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
|
||
| Completed |
NCT03876041 -
Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome
|
Phase 4 | |
| Recruiting |
NCT05608096 -
European Registry for Hemadsorption in Sepsis With the Seraph Filter
|
||
| Completed |
NCT02568410 -
Platelets as Regulators of Inflammation in Cardiac Surgery
|
||
| Completed |
NCT01636232 -
Vitamin D and Critically Ill Patients
|
N/A | |
| Completed |
NCT01020409 -
INFLACOR - Clinical and Genetic Predictors of Inflammation Related Complications After Heart Surgery
|
Phase 4 | |
| Completed |
NCT04624776 -
Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest
|
Phase 2 | |
| Recruiting |
NCT05172739 -
Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC
|
Phase 4 | |
| Recruiting |
NCT02957175 -
Immunophenotyping of Patients With Postoperative SIRS
|
||
| Completed |
NCT02320539 -
MicroRNA Diagnostics in Subarachnoid Hemorrhage 2
|
N/A | |
| Completed |
NCT01708759 -
IL8 Monitoring and Its Correlation With 251-gene Polymorphism
|
N/A | |
| Terminated |
NCT00708799 -
Efficacy of Macrolide Immunomodulation in Severe Sepsis.
|
Phase 2 | |
| Recruiting |
NCT04580680 -
Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)
|
||
| Recruiting |
NCT05663216 -
Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome
|